Phase II Study of Camtobell Inj.(Belotecan) in Combination With Cisplatin in Patients With Previously Untreated, Extensive-Stage Small-Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2014
At a glance
- Drugs Belotecan (Primary) ; Cisplatin
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Nov 2008 Status changed from not yet recruiting to recruiting.
- 08 Oct 2008 Additional trial identifier YONSEI-07-YUHS-02 added as reported by ClinicalTrials.gov.
- 06 Oct 2008 New trial record.